- Home
- Responsibility
- CR Review 2007
- Case studies
- Contribution to global health
Case study
Helping to manage chronic diseases in the US
Healthcare costs in the US are a concern for patients, healthcare payers and the pharmaceutical industry alike. The increase in prevalence of chronic diseases such as diabetes and heart disease is a major contributory factor.
We are working with governments and employers to address the problem of chronic diseases while reducing healthcare costs. Our approach, known as the 'triple solution', has three focus areas:
- Prevention - addressing the causes of chronic diseases
- Intervention - managing chronic diseases to prevent costly complications
- Innovation - developing new treatments for unmet medical needs
Ensuring patients are appropriately treated - which includes checkups, diet and exercise and adhering to medical treatment - brings benefits for patients, payers and for GSK. To that end, we work with employers to: identify the diseases that put the greatest burden on healthcare budgets; provide preventive services to workers such as regular health screening; and develop disease management programmes which help employees control their symptoms and stick to their treatment.
So far GSK has worked with more than 200 employers to reduce healthcare expenditure and absence from work due to ill health.
